Translational research in cancer complementary and alternative medicine: the National Cancer Institute's Best Case Series Program.
Public interest in CAM for cancer care likely will influence the need for continued scientific evaluation. The NCI BCS program evaluates case studies involving novel alternative therapies for cancer treatment. Through the NCI BCS program, meaningful data are generated that may lead to NCI-supported research projects, including prospective studies, clinical trials, and advances in scientific knowledge. Individuals interested in obtaining a submission packet for the NCI BCS program may access the official OCCAM Web site at http://www3.cancer.gov/occam/ or call 301-435-7980.
Lee
Colleen O
CO
Office of Cancer Complementary and Alternative Medicine, National Cancer Institute in Bethesda, MD, USA. leeco@mail.nih.gov
D000529:Complementary Therapies; D006801:Humans; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000628:therapy*; D017712:Peer Review, Research; D014481:United States